Mitoxantrone chemotherapeutic data

Phase III data showed reduction in pain with Mitoxantrone compared to a standard treatment, prednisone.

Of 80 patients, 23 receiving the two drugs had marked reduction in pain compared to 10 of 81 patients receiving only prednisone (p= 0.033). There was no difference in survival rates. ...